Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very ...
The effects worsen over time, making daily functioning increasingly difficult. Although there is no cure, research shows that ...
More than 6 million Americans, and millions more worldwide, have Alzheimer’s. A handful of genes are known to cause rare ...
Results of the study showed multiple patterns of cognitive strengths and weaknesses and Alzheimer's disease risk and may ...
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have ...
This overlap makes it particularly challenging to pinpoint Alzheimer’s as the cause of symptoms. One of the first hurdles in diagnosing Alzheimer ... assessments to rule out other conditions and may ...
In people with Alzheimer’s disease, brain cells die and connections between brain cells may break down ... behavioral changes are often the first symptoms of frontotemporal dementia.
and explains why these signs may differ from those seen in men. Alzheimer’s disease progresses gradually, and its symptoms can be subtle at first. The reason behind the higher incidence in women ...
Human brains have been steadily growing through the decades, and that may be lowering the risk of dementia. A new study out of UC Davis Health found that people born in the 1970s had brain ...
This new study supports a growing hypothesis that RT inhibitors may also decrease progression of similar enzymes in the brain that link to Alzheimer’s. A key study finding focuses on the ...
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have ...